Monday, October 14, 1996
WASHINGTON - The FDA last week reiterated its prohibitions
on free dissemination of information by product sponsors. The publication of
final versions of guidance documents about dissemination of articles and reference
texts by manufacturers of FDA-regulated products as the agency is scheduled
to convene on Wednesday a two-day meeting about promotion of FDA-regulated medical
products on the Internet.
The final documents, "Guidance to Industry on Dissemination
of Reprints of Certain Published, Original Data" and "Guidance for Industry
Funded Dissemination of Reference Texts," were published in the Federal Register.